Maejima and colleagues demonstrated that telmisartan, a partial PPAR-γ agonist, could reduce TGF-β1 expression post-MI by activating PPAR-γ in the noninfarcted myocardium in rats [28]. This evidence concerns the gene PPARG and myocardial infarction.